Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

The FDA has removed the REMS program requirement for currently approved BCMA- and CD19-directed autologous CAR T-cell therapies.

Adding ibrutinib to rituximab improved outcomes in patients with previously untreated FL who were ineligible for CIT.

The ACIP has recommended that patients only receive seasonal influenza vaccines that do not contain thimerosal.

From 2001 to 2019, breast cancer incidence increased in women who were 65-74 years of age, remained stable in those who were 75-84 years of age, and decreased in those who were 85 years or older. New ...

Subcutaneous isatuximab administered via an on-body injector appears to be as safe and effective as intravenous isatuximab in patients with relapsed or refractory multiple myeloma.

The FDA has approved updated labels for Breyanzi and Abecma, removing the REMS programs and reducing certain restrictions.

Earlier this year, as President Donald Trump was beginning to reshape the American government, Michael, an emergency room doctor who was born, raised, and trained in the United States, packed up his ...

In 2024, 27.2 million people of all ages were uninsured in the United States, according to early estimates from the National Health Interview Survey.

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

On June 9, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr replaced all 17 ACIP members. 3 He noted that all of these members had been appointed by the Biden administration and said a ...

Susan Monarez, 50, told senators she values “evidence-based decision-making” and believes “vaccines save lives.” But she declined to say whether she disagrees with recent decisions by Health and Human ...